Larvol Delta - 89bio-to-Present-48Week-Data-from-ENLIVEN-Phase-2b-Pegozafermin-Trial-in-Metabolic-DysfunctionAssociated-Steatohepatitis-MASH-at-EASL-International-Liver-Congress

pegozafermin (BIO89-100) - 89Bio

https://www.globenewswire.com/news-release/2024/05/22/2886846/0/en/89bio-to-Present-48-Week-Data-from-ENLIVEN-Phase-2b-Pegozafermin-Trial-in-Metabolic-Dysfunction-Associated-Steatohepatitis-MASH-at-EASL-International-Liver-Congress.html

May 22, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next